Source: http://news.feedzilla.com/en_us/stories/politics/top-stories/289870788?client_source=feed&format=rss
Taylor Swift Red Walking Dead Season 3 Episode 2 celiac disease san francisco giants Medal of Honor Warfighter Richard Mourdock d
Friday, March 8, 2013
An Amazing Menagerie of Animal Prostheses [Video]
FUJI, THE DOLPHIN
Winter's not the first dolphin to receive a prosthesis?that distinction goes to Fuji, who had the end of her tail amputated after contracting a mysterious necrotic disease. Fuji, who lives in an aquarium in Japan, lost a much smaller portion of her tail?just her back fin?than Winter did, but she also struggled to adapt to her new body. So volunteers at tire-manufacturer Bridgestone came to the rescue, reportedly spending $83,000 to build Fuji a prosthetic fin made of rubber and carbon fiber.
MOTALA & MOSHA, THE ELEPHANTS
Motala and Mosha are Asian elephants who lost their legs after stepping on land mines along the Thailand?Burma border. The pachyderms ended up at the Friends of the Asian Elephant Hospital in Lampang, Thailand, where Soraida Salwala spent years trying to build the animals brand new limbs. It?s not easy to build prosthetics for animals that weigh 2,700 kilograms?veterinarians and prosthetists had to invent a new technique just to take casts of the animals? stumps?but today, both elephants are lumbering around on their new legs, made from a combination of plastic and metal. (The prosthetists fashioned the ankle joint out of parts from a car engine.) The elephants? story is chronicled in the 2012 documentary, The Eyes of Thailand.
BEAUTY, THE BALD EAGLE
In 2005 a poacher shot Beauty in the face. The bullet destroyed most of the top half of her beak, leaving her unable to eat or groom herself. Beauty was rescued by Birds of Prey Northwest, and Nate Calvin, a mechanical engineer and the founder of the Kinetic Engineering Group, set out to make her a new upperbeak. Calvin made a mold of what remained of Beauty?s beak and then designed a prosthetic using a 3-D modeling software. He printed the beak, which was made of a nylon polymer, using a 3-D printer. With the prosthetic attached to her face, Beauty can now eat on her own.
TZVIKA, THE TURTLE
A run-in with a lawnmower left Tzvika with a broken shell and a damaged spine?and her back legs very weak. Veterinarians in Israel restored the female turtle?s mobility by attaching a set of wheels to the underside of her shell. The wheels also elevate Tzvika?s body, preventing her from dragging her legs and shell along the ground and sustaining further injury. A handful of other legless turtles have also been outfitted with wheels.
NAKI?O, THE DOG
When Naki?o was just his puppy, he got his paws stuck in a frozen puddle. All four frostbitten appendages were amputated. As the cattle dog grew up, it became increasingly difficult for him to move around on his stumps. Fortunately, OrthoPets, a Denver company that designs orthotic and prosthetic devices for companion animals, came to the rescue: It outfitted Naki?o with four artificial paws, reportedly making him the first dog to have four prosthetic limbs.
Source: http://rss.sciam.com/click.phdo?i=b8f6b06027704671c0c91bf8a9d28436
angelman syndrome total recall troy tulowitzki katie couric good morning america the rock vs john cena acm awards 2012 january jones
Thursday, March 7, 2013
How the brain suppresses pain during times of stress
Mar. 6, 2013 ? New findings about how the brain functions to suppress pain have been published in the leading journal in the field Pain, by National University of Ireland Galway (NUI Galway) researchers. For the first time, it has been shown that suppression of pain during times of fear involves complex interplay between marijuana-like chemicals and other neurotransmitters in a brain region called the amygdala.
The work was carried out by Dr David Finn and his research team in Pharmacology and Therapeutics, Centre for Pain Research and Galway Neuroscience Centre at the National Centre for Biomedical Engineering Science, NUI Galway. The research builds on previous breakthrough findings from Dr Finn's research group on the role of marijuana-like chemicals in the brain's hippocampus in pain suppression during fear.
Pain is both a sensory and an emotional experience and is subject to modulation by a number of factors including fear and stress. During exposure to a high-stress environment or stimulus, pain transmission and perception can be potently suppressed. This important survival response can help us cope with or escape from potentially life-threatening situations. One brain region that is integral to the processing and expression of both emotional responses and pain is the amygdala.
Working with Dr Finn, first author Dr Kieran Rea was able to confirm the amygdala as a key brain region in the suppression of pain behaviour by fear (so-called fear-induced analgesia). Fear-induced analgesia was associated with increases in levels of marijuana-like substances known as endocannabinoids in the amygdala.
Furthermore, fear-induced analgesia was prevented by injecting a drug that blocked the receptor at which these endocannabinoids act into the amygdala. Further experimentation revealed that these effects involved an interaction between endocannabinoids and the classical neurotransmitters GABA (Gamma-amino butyric acid) and glutamate. An increased understanding of the biological mechanisms involved in fear-induced analgesia is important from a fundamental physiological perspective and may also advance the search for new therapeutic approaches to the treatment of pain.
Dr David Finn, Leader of the Galway Neuroscience Centre, Co-Director of the Centre for Pain Research at NUI Galway and study leader says: "The body can suppress pain when under extreme stress, in part through the action of marijuana-like substances produced in the brain. This research provides information on the complex interactions between multiple neurotransmitter systems including endocannabinoids, GABA and glutamate in times of stress and pain. This research which was funded by a grant from Science Foundation Ireland, advances our fundamental understanding of the neurobiology of pain and may facilitate the identification of new therapeutic targets for the treatment of pain and anxiety disorders."
Share this story on Facebook, Twitter, and Google:
Other social bookmarking and sharing tools:
Story Source:
The above story is reprinted from materials provided by National University of Ireland, Galway, via AlphaGalileo.
Note: Materials may be edited for content and length. For further information, please contact the source cited above.
Journal Reference:
- Kieran Rea, Weredeselam M. Olango, Brendan Harhen, Daniel M. Kerr, Rachel Galligan, Sean Fitzgerald, Maeve Moore, Michelle Roche, David P. Finn. Evidence for a role of GABAergic and glutamatergic signalling in the basolateral amygdala in endocannabinoid-mediated fear-conditioned analgesia in rats. PAIN, 2012; DOI: 10.1016/j.pain.2012.12.021
Note: If no author is given, the source is cited instead.
Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of ScienceDaily or its staff.
Source: http://feeds.sciencedaily.com/~r/sciencedaily/top_news/top_health/~3/Wasfc2W_yrE/130306134014.htm
rimm pauly d project adrienne rich autism cesar chavez day raspberry ketone ron burgundy
Hotel Maurya Palace Payday Loans For Poor Credit Easy And Fast ...
March 6, 2013???
In the case of availing the best income give you support dont need to have to wait ever again. In the current action-packed age you get their hands on the actual finance in front of the pay day advance. The pay day loans regarding a bad credit score is very fame from the mortgage market of Uk. These financing options are meant to provide the instant cash aid to all the fought folks to mask all growing costs effectively between his or her how to get a loan a pair of paydays. These plans tend to be brought to take care of most unforeseen expenditures without failing.
For which purposes you may make utilization of payday advances pertaining to a low credit score. This sort of costs incorporate health check-up charges, unpaid bills, credited permit room expenses, grocery store expenses, childs school as well as educational costs charges, catalogue expenses, bank loan installments and the record continues on. Apart from remember that the presented fund must be given back right up until your following cash advance so you should remember fondly the payment night out.
1500 loan There won?t be any precise 1000 loans regulations to be followed. Thats what you need to fulfill a number of regular argument such as you are either adult as well as 20 yrs . old of age, you?re citizen associated with Uk, you?ve got a valid active checking account and you have a full-time task from the very last six months herewith getting around 1000 a month. On following these types of situations you can enjoy pay day loans pertaining to poor credit in spite of virtually any people?s credit reports.
Therefore, individuals struggling with credit history troubles which include CCJs, Individual voluntary arrangement, home foreclosure, omitting of obligations, fails, financial obligation, liquidation, overdue installments and which can be accepted to acquire the particular fund through pay day loans with regard to poor credit. Really, these plans are generally made to aid people who have credit score complication. Most applicants who desire pertaining to availing these refinancing options because they can access the economic assist starting from 100 to be able to 1,000 along with the pay for has got to repaid within 15 for you to Thirty-one times.
Absolutely no collateral required towards therefore, people existing while actuel can also take fiscal establishments without experiencing any difficulty. For quick financial aid you have to go with online mode that?s an easy along with instantaneous application process positioned on the site from the loan. Throughout form you have to fill out your own details accurately and then, submit it online. Soon after endorsement of the details, the particular finance can be deposited one on one to your account safely about the very same day?s using. This particular on-line request services assists you to connect to the account without expecting much time. In addition, it?s not necessary to be able to fax any essential document.
Source: http://www.hotelmauryapalace.com/payday-loans-for-poor-credit-easy-and-fast-cash-despite-bad-credit/
rex ryan PNC Bank Louisville football Fidelity pnc Charlie Strong Calendar 2013
MP hails University of Chester's planned expansion
CITY MP Stephen Mosley has welcomed the University of Chester?s planned expansion.
University leaders hope to create up to 2,000 jobs and attract students from around the world after taking over Shell UK?s research and development base in Thornton.
Professor Tim Wheeler, university vice chancellor, said an engineering and technology faculty would be created on the 66-acre site.
More than 20 businesses with high growth potential will be offered ?incubator? space and access to specialist knowledge, expertise, facilities and equipment at the former Shell Technology Centre.
Prof Wheeler said the university would also establish a dedicated science park in a bid to attract multi-national companies to the region.
Mr Mosley said: ?This is a once-in-a-lifetime opportunity for any university, and it is fantastic it is our very own University of Chester which is set to benefit.
?The facilities at Thornton are world-class and I cannot wait for our students and local businesses to be able to benefit from them.
?The fact that this deal is set to go ahead is testament to the hard work of all stakeholders, and also a vote of confidence in our city?s university, students, and economy.?
Shell UK confirmed last year the research base would close in 2014 with about 500 jobs being relocated to Germany, Manchester and London.
Prof Wheeler said the university would move onto the site ? which includes laboratories, workshops, offices, sports facilities and a restaurant ? in phases over the next 18 months.
He said the university would be investing in the site using Government funding, income from recruiting 500 students, rent from businesses based on the site and consultancy fees from research projects.
The first students will be admitted in 2014 with two buildings being adapted to provide a learning resource centre, teaching spaces and laboratories.
New subjects offered will include geotechnical engineering, mechanical engineering and electrical engineering.
Prof Wheeler said: ?The University of Chester has long been synonymous with ensuring Cheshire West and Chester is ?open for business? and our commitment at Thornton could bring up to 2,000 jobs over the next five years.
?Thornton, with 1,100,000 square feet of space in 48 buildings, is the most substantial acquisition in the university?s history, as the institution enters its 175th year and the next phase in its evolution, which should see it sitting more prominently on the international stage ? and taking Cheshire West and Chester with it.?
Source: http://www.chesterfirst.co.uk:80/news/120533/mp-hails-university-of-chester-s-planned-expansion.aspx
Selena Gomez ariel winter Paige Butcher David Petraeus Petraeus Mia Love wall street journal
Wednesday, March 6, 2013
New study suggests potential shift in burden of pneumococcal disease
![[ Back to EurekAlert! ]](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_svCu1uhYWBD3Zuhblwztm2PZ0gzBaQyGk-kME1lQeurs2OsOUsQ8CGn66v0TMXmYy1v2E8qua8V2oTnuyudTJBtPhx-XCZkyBjgII4YD4=s0-d){kind=small}
Public release date: 5-Mar-2013[ | E-mail |
Share ] Contact: Johanna Harvey
johanna.harvey@sabin.org
202-621-1691
Sabin Vaccine Institute
A high economic burden may also be associated with the disease in Latin America
Sao Paulo, Brazil - March 5, 2013 New studies revealed today by Latin American researchers and global health leaders suggest that the highest burden of deadly pneumococcal disease in Latin America may be shifting to adults as countries successfully immunize more infants with new vaccines. The experts called for increased disease monitoring and more surveillance to understand the full extent of pneumococcal disease in the Americas, including its economic impact, and to devise effective strategies to prevent it.
This research was coordinated by the Sabin Vaccine Institute in partnership with the Pan American Health Organization (PAHO), the International Vaccine Access Center at Johns Hopkins University (JHU's IVAC) and the Centers for Disease Control and Prevention (CDC). These results are being presented as part of a two-day symposium that brought together scientists and health leaders to review the pneumococcal situation in the region and discuss the challenges and opportunities of vaccination in older children and adult populations
The recent studies that are available in the Latin American and Caribbean context indicate that the cost of illness is an important and significant economic burden, suggesting that more use of pneumococcal vaccines could be cost-effective in adults, said Dr. Fernando de la Hoz, a member of the Medical Faculty at the National University of Colombia and lead author of the study. Further research is needed in order for health officials to fully grasp the potential impact of immunizing older populations in Latin America and the Caribbean. We know now that the vaccine is saving the lives of thousands of our regions youngest citizens. The question is whether we should also be protecting their parents and grandparents.
The study found that direct medical costs to treat bacteremic pneumonia ranged from USD $993 to USD $3,535 per person, and the cost of treatment for bacteremic meningitis was as high as USD $4,490 for elderly persons. The cost analysis concluded that these diseases pose sizable burdens in five countries studied: Argentina, Brazil, Chile, Colombia and Uruguay.
Pneumococcal disease, which causes pneumonia, blood infection, brain inflammation and ear infections kills half a million children worldwide each yearor one child every minute. Thanks to new and improved vaccines, pneumococcal disease among young children is falling dramatically. Since childhood pneumococcal conjugate vaccines were introduced in Latin America in 2003, the disease is declining among children who are vaccinated, and the burden of disease may now be in the older population. Adults and the elderly across Latin America who also fall prey to this fast-acting disease arent getting vaccines, and relatively little was known about the number of pneumococcal-related deaths in these age groups.
Recognizing the intrinsic danger of some types of pneumococcal disease, researchers found case fatality rates can be as high as 35 percent in studies from Argentina, Brazil, Chile and Uruguay. For pneumococcal meningitis, studies in seven countries found that the percentage of people who died after being infected ranged from 9 percent to 58 percent.
As people continue to live longer lives, more of them will be at risk of contracting this highly contagious and costly disease, said Carla Domingues of the Brazilian Ministry of Health. The data reviewed during this study suggests that pneumococcal disease is an important problem among adults, causing disease and death from pneumonia, sepsis and meningitis.
A major finding of the study is that there is insufficient monitoring and surveillance. Quantifying the burden of disease for people 5 years of age and older in the Latin America and Caribbean region is important because pneumococcal conjugate vaccines (PCVs) are increasingly being introduced into routine infant immunization programs and are expected to greatly reduce the burden of pneumococcal disease among young children. Thus, prevention of pneumococcal disease among other high-risk groups such as the elderly or immuno-compromised will become increasingly important, said Lucia Helena de Oliveira, Regional Advisor of the Comprehensive Family Immunization Project at the Pan American Health Organization.
Experts examined the cost of illness for pneumococcal disease in older persons in five countries: Argentina, Brazil, Chile, Colombia and Uruguay. They found that in these countries, invasive pneumococcal disease (IPD) incurs considerable costs to health care systemsgenerating up to US$4,490 per case. Researchers also found the total health care costs in the studied countries ranged from USD $0.94 million to 14.1 million, with higher costs incurred by the elderly due to higher level of resources used for treating the elderly. In total, health care spending as a GDP per capita for IPD among people above 5 years of age in the region was estimated at 0.1 percent compared to the reported 8 to 10 percent of GDP spent on health care overall.
The study authors are calling on policymakers to prioritize adult pneumococcal disease on their public health agendas, so healthcare professionals will devote more resources to detect and report on occurrences of the disease and find ways to combat it.
Great determination and collaboration among the international health community helped make global reductions in pediatric pneumococcal disease possible. It is time to transition this success to find solutions to prevent pneumococcal infections in older children and adults, especially those over 65, said Dr. Ciro de Quadros, Executive Vice President of the Sabin Vaccine Institute.
###
About Sabin Vaccine Institute
Sabin Vaccine Institute is a non-profit, 501(c)(3) organization of scientists, researchers, and advocates dedicated to reducing needless human suffering caused by vaccine preventable and neglected tropical diseases. Sabin works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the world's most pervasive health challenges. Since its founding in 1993 in honor of the oral polio vaccine developer, Dr. Albert B. Sabin, the Institute has been at the forefront of efforts to control, treat and eliminate these diseases by developing new vaccines, advocating use of existing vaccines and promoting increased access to affordable medical treatments. For more information please visit www.sabin.org.
About the Pan America Health Organization
The Pan American Health Organization (PAHO) is an international public health agency with more than 100 years of experience in working to improve health and living standards of the countries of the Americas. It serves as the specialized organization for health of the Inter-American System. It also serves as the Regional Office for the Americas of the World Health Organization and enjoys international recognition as part of the United Nations system.
About The International Vaccine Access Center (IVAC)
The International Vaccine Access Center (IVAC) has as its mission to accelerate global access to life-saving vaccines through the development and implementation of evidence-based policies. Drawing upon expertise and faculty from the Johns Hopkins Bloomberg School of Public Health, IVAC works to strengthen the evidence base for vaccine introduction including undertaking targeted, policy-focused research in areas such as disease burden, cost-effectiveness, vaccine policy, demand forecasting and disease epidemiology. For more information, please visit www.jhsph.edu/ivac.
About the Centers for Disease Control and Prevention (CDC)
The Centers for Disease Control and Prevention (CDC), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting public health activities in the United States. CDC's focus is not only on scientific excellence but also on the essential spirit that is CDC to protect the health of all people. CDC keeps humanity at the forefront of its mission to ensure health protection through promotion, prevention, and preparedness. For more information, please visit www.cdc.gov.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Public release date: 5-Mar-2013[ | E-mail |
Share ] Contact: Johanna Harvey
johanna.harvey@sabin.org
202-621-1691
Sabin Vaccine Institute
A high economic burden may also be associated with the disease in Latin America
Sao Paulo, Brazil - March 5, 2013 New studies revealed today by Latin American researchers and global health leaders suggest that the highest burden of deadly pneumococcal disease in Latin America may be shifting to adults as countries successfully immunize more infants with new vaccines. The experts called for increased disease monitoring and more surveillance to understand the full extent of pneumococcal disease in the Americas, including its economic impact, and to devise effective strategies to prevent it.
This research was coordinated by the Sabin Vaccine Institute in partnership with the Pan American Health Organization (PAHO), the International Vaccine Access Center at Johns Hopkins University (JHU's IVAC) and the Centers for Disease Control and Prevention (CDC). These results are being presented as part of a two-day symposium that brought together scientists and health leaders to review the pneumococcal situation in the region and discuss the challenges and opportunities of vaccination in older children and adult populations
The recent studies that are available in the Latin American and Caribbean context indicate that the cost of illness is an important and significant economic burden, suggesting that more use of pneumococcal vaccines could be cost-effective in adults, said Dr. Fernando de la Hoz, a member of the Medical Faculty at the National University of Colombia and lead author of the study. Further research is needed in order for health officials to fully grasp the potential impact of immunizing older populations in Latin America and the Caribbean. We know now that the vaccine is saving the lives of thousands of our regions youngest citizens. The question is whether we should also be protecting their parents and grandparents.
The study found that direct medical costs to treat bacteremic pneumonia ranged from USD $993 to USD $3,535 per person, and the cost of treatment for bacteremic meningitis was as high as USD $4,490 for elderly persons. The cost analysis concluded that these diseases pose sizable burdens in five countries studied: Argentina, Brazil, Chile, Colombia and Uruguay.
Pneumococcal disease, which causes pneumonia, blood infection, brain inflammation and ear infections kills half a million children worldwide each yearor one child every minute. Thanks to new and improved vaccines, pneumococcal disease among young children is falling dramatically. Since childhood pneumococcal conjugate vaccines were introduced in Latin America in 2003, the disease is declining among children who are vaccinated, and the burden of disease may now be in the older population. Adults and the elderly across Latin America who also fall prey to this fast-acting disease arent getting vaccines, and relatively little was known about the number of pneumococcal-related deaths in these age groups.
Recognizing the intrinsic danger of some types of pneumococcal disease, researchers found case fatality rates can be as high as 35 percent in studies from Argentina, Brazil, Chile and Uruguay. For pneumococcal meningitis, studies in seven countries found that the percentage of people who died after being infected ranged from 9 percent to 58 percent.
As people continue to live longer lives, more of them will be at risk of contracting this highly contagious and costly disease, said Carla Domingues of the Brazilian Ministry of Health. The data reviewed during this study suggests that pneumococcal disease is an important problem among adults, causing disease and death from pneumonia, sepsis and meningitis.
A major finding of the study is that there is insufficient monitoring and surveillance. Quantifying the burden of disease for people 5 years of age and older in the Latin America and Caribbean region is important because pneumococcal conjugate vaccines (PCVs) are increasingly being introduced into routine infant immunization programs and are expected to greatly reduce the burden of pneumococcal disease among young children. Thus, prevention of pneumococcal disease among other high-risk groups such as the elderly or immuno-compromised will become increasingly important, said Lucia Helena de Oliveira, Regional Advisor of the Comprehensive Family Immunization Project at the Pan American Health Organization.
Experts examined the cost of illness for pneumococcal disease in older persons in five countries: Argentina, Brazil, Chile, Colombia and Uruguay. They found that in these countries, invasive pneumococcal disease (IPD) incurs considerable costs to health care systemsgenerating up to US$4,490 per case. Researchers also found the total health care costs in the studied countries ranged from USD $0.94 million to 14.1 million, with higher costs incurred by the elderly due to higher level of resources used for treating the elderly. In total, health care spending as a GDP per capita for IPD among people above 5 years of age in the region was estimated at 0.1 percent compared to the reported 8 to 10 percent of GDP spent on health care overall.
The study authors are calling on policymakers to prioritize adult pneumococcal disease on their public health agendas, so healthcare professionals will devote more resources to detect and report on occurrences of the disease and find ways to combat it.
Great determination and collaboration among the international health community helped make global reductions in pediatric pneumococcal disease possible. It is time to transition this success to find solutions to prevent pneumococcal infections in older children and adults, especially those over 65, said Dr. Ciro de Quadros, Executive Vice President of the Sabin Vaccine Institute.
###
About Sabin Vaccine Institute
Sabin Vaccine Institute is a non-profit, 501(c)(3) organization of scientists, researchers, and advocates dedicated to reducing needless human suffering caused by vaccine preventable and neglected tropical diseases. Sabin works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the world's most pervasive health challenges. Since its founding in 1993 in honor of the oral polio vaccine developer, Dr. Albert B. Sabin, the Institute has been at the forefront of efforts to control, treat and eliminate these diseases by developing new vaccines, advocating use of existing vaccines and promoting increased access to affordable medical treatments. For more information please visit www.sabin.org.
About the Pan America Health Organization
The Pan American Health Organization (PAHO) is an international public health agency with more than 100 years of experience in working to improve health and living standards of the countries of the Americas. It serves as the specialized organization for health of the Inter-American System. It also serves as the Regional Office for the Americas of the World Health Organization and enjoys international recognition as part of the United Nations system.
About The International Vaccine Access Center (IVAC)
The International Vaccine Access Center (IVAC) has as its mission to accelerate global access to life-saving vaccines through the development and implementation of evidence-based policies. Drawing upon expertise and faculty from the Johns Hopkins Bloomberg School of Public Health, IVAC works to strengthen the evidence base for vaccine introduction including undertaking targeted, policy-focused research in areas such as disease burden, cost-effectiveness, vaccine policy, demand forecasting and disease epidemiology. For more information, please visit www.jhsph.edu/ivac.
About the Centers for Disease Control and Prevention (CDC)
The Centers for Disease Control and Prevention (CDC), a part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting public health activities in the United States. CDC's focus is not only on scientific excellence but also on the essential spirit that is CDC to protect the health of all people. CDC keeps humanity at the forefront of its mission to ensure health protection through promotion, prevention, and preparedness. For more information, please visit www.cdc.gov.
[ | E-mail | Share ] ?
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.
Source: http://www.eurekalert.org/pub_releases/2013-03/svi-nss030413.php
arpaio carol burnett neil degrasse tyson neil degrasse tyson davy jones death born this way foundation lytro camera
Video: Capitalizing on Personal Greetings
Sorry, Readability was unable to parse this page for content.
Source: http://www.nbcnews.com/video/cnbc/51048015/
pilar sanders andrew young real life barbie zipper armenian genocide asteroid mining memorial day
Subscribe to:
Posts (Atom)